ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
62,820.39
-1.44%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Adicet Bio Inc (ACET)

  7. Adicet Bio Inc (ACET) Noticias

ACET Adicet Bio Inc

1.73
-0.08 (-4.42%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Adicet Bio Inc ACET NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.08 -4.42% 1.73 17:52:14
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.81 1.66 1.825 1.68 1.81
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/4/202415:30BWAdicet Bio Highlights Preclinical Data Supporting IND..
08/4/202406:00BWAdicet Bio to Participate in 2024 Canaccord Genuity Horizons..
28/3/202416:19BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
19/3/202415:10BWAdicet Reports Fourth Quarter and Full Year 2023 Financial..
11/3/202406:00BWAdicet Bio to Participate in a Fireside Chat at the H.C...
29/2/202418:46BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
05/2/202415:01BWAdicet Bio to Participate in a Fireside Chat at the..
02/2/202410:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202415:39BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
26/1/202418:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202418:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202415:01BWAdicet Bio, Inc. Announces Closing of $98 Million Public..
24/1/202415:34EDGAR2Form 8-K - Current report
24/1/202415:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/1/202422:43BWAdicet Bio, Inc. Announces Pricing of Public Offering
22/1/202415:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/1/202415:28BWAdicet Bio, Inc. Announces Proposed Public Offering
19/1/202415:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
16/1/202406:01EDGAR2Form 8-K - Current report
04/1/202406:17EDGAR2Form 8-K - Current report
04/1/202406:00BWAdicet Provides Corporate Update and Highlights Strategic..
03/1/202415:01BWAdicet Bio to Host Conference Call to Provide Updates on its..
29/12/202315:50BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
10/12/202311:00BWAdicet Bio Highlights ADI-001 Expansion, Persistence and..
13/11/202315:42EDGAR2Form 8-K - Current report
08/11/202315:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:12EDGAR2Form 8-K - Current report
08/11/202315:10BWAdicet Reports Third Quarter 2023 Financial Results and..
07/11/202306:00BWAdicet Bio to Present at the 2023 Jefferies London..
02/11/202308:00BWAdicet Bio Announces Poster Presentation Highlighting..
31/10/202317:25BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
16/10/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202311:00BWAdicet Bio Announces Poster Presentation at the Upcoming..
03/10/202315:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202316:24BWAdicet Bio Reports Inducement Grants under Nasdaq Listing..
27/9/202308:00BWAdicet Bio to Present Three Scientific Posters Highlighting..
31/8/202315:35BWAdicet Bio Reports Inducement Grants under Nasdaq Listing..
16/8/202317:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202317:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202317:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202317:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
09/8/202315:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202315:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:17EDGAR2Form 8-K - Current report
09/8/202315:15BWAdicet Reports Second Quarter 2023 Financial Results and..
02/8/202315:00BWAdicet Bio to Participate in a Fireside Chat at the..
31/7/202315:50BWAdicet Bio Reports Inducement Grants under Nasdaq Listing..

Su Consulta Reciente

NASDAQ
ACET
Adicet Bio
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados